Global Therapeutics Pty Ltd

Regulatory action due to It appeared to the Secretary that the presentation of the goods was unacceptable.As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(j) was incorrect.The goods do not conform to a standard applicable to the goods., effective 26/02/2016